Cargando…

Complete response of myeloid/lymphoid neoplasms with PDGFRA rearrangement presenting as leukemia/myeloid sarcoma to imatinib monotherapy

Detalles Bibliográficos
Autores principales:	Ma, Rui, Huang, Xiao-Jun, Jia, Jin-Song, Kong, Jun, Qin, Ya-Zhen, Jiang, Hao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2019
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6831079/ https://www.ncbi.nlm.nih.gov/pubmed/31567386 http://dx.doi.org/10.1097/CM9.0000000000000437

Ejemplares similares

Myeloid/lymphoid neoplasm with eosinophilia and rearrangement of PDGFRA presenting as myeloid sarcoma
por: Barouqa, Mohammad, et al.
Publicado: (2022)

A tricky and rare cause of pulmonary eosinophilia: myeloid/lymphoid neoplasm with eosinophilia and rearrangement of PDGFRA
por: Zanelli, Magda, et al.
Publicado: (2019)

Case Report: Evolution of KIT D816V-Positive Systemic Mastocytosis to Myeloid Neoplasm With PDGFRA Rearrangement Responsive to Imatinib
por: Sciumè, Mariarita, et al.
Publicado: (2021)

Case Report: Pediatric myeloid/lymphoid neoplasm with eosinophilia and PDGFRA rearrangement: The first case presenting as B-lymphoblastic lymphoma
por: Akiely, Reem, et al.
Publicado: (2022)

Sustained Complete Molecular Remission With Imatinib Monotherapy in a Child Presenting With Blast Phase FIP1L1-PDGFRA-Associated Myeloid Neoplasm With Eosinophilia
por: Jain, Juhi, et al.
Publicado: (2020)

Imatinib-Associated Tumor Lysis Syndrome in a Patient With Myeloid Neoplasm With Eosinophilia and PDGFRA Rearrangement: A Case Report and Review of the Literature
por: Socola, Francisco, et al.
Publicado: (2017)

Multiple Eruptive Dermatofibromas Secondary to Imatinib Mesylate in a Patient with Chronic Myeloid Leukemia
por: Lira-Valero, Francisco J, et al.
Publicado: (2021)

P1073: MUTATIONAL LANDSCAPE AND CLINICAL OUTCOMES OF PATIENTS WITH MYELOID AND LYMPHOID NEOPLASMS WITH EOSINOPHILIA (MLN-EOS) AND ABNORMALITIES OF PDGFRA, PDGFRB, FGFR1, FLT3 AND JAK REARRANGEMENT
por: Zhang, Y., et al.
Publicado: (2022)

A rare cause of persistent leukocytosis with massive splenomegaly: Myeloid neoplasm with BCR-PDGFRA rearrangement—Case report and literature review
por: Gao, Lu, et al.
Publicado: (2022)

Kaposi’s sarcoma associated with chronic myeloid leukemia and imatinib mesylate therapy
por: D’Addona, Matteo, et al.
Publicado: (2022)

Acquisition of mixed lineage leukemia rearrangement in a chronic myeloid leukemia patient while on imatinib
por: Zámečníkova, Adriana
Publicado: (2011)

Discovery of imatinib-responsive FIP1L1-PDGFRA mutation during refractory acute myeloid leukemia transformation of chronic myelomonocytic leukemia
por: Shah, Shilpan, et al.
Publicado: (2014)

Refractory myeloid sarcoma with a FIP1L1-PDGFRA rearrangement detected by clinical high throughput somatic sequencing
por: Mandelker, Diana, et al.
Publicado: (2015)

Comprehensive genomic profiling identifies a novel TNKS2–PDGFRA fusion that defines a myeloid neoplasm with eosinophilia that responded dramatically to imatinib therapy
por: Chalmers, Z R, et al.
Publicado: (2015)

Myeloid/lymphoid neoplasms associated with eosinophilia and rearrangements of PCM1::JAK2 with erythroblastic sarcoma: a case report and literature review
por: Zhang, Lina, et al.
Publicado: (2023)

Imatinib in Chronic Myeloid Leukemia: an Overview
por: Sacha, Tomasz
Publicado: (2014)

Long-term efficacy and safety of dasatinib in patients with chronic myeloid leukemia in accelerated phase who are resistant to or intolerant of imatinib
por: Ottmann, Oliver, et al.
Publicado: (2018)

Myeloid Neoplasms with t(5;12) and ETV6-ACSL6 Gene Fusion, Potential Mimickers of Myeloid Neoplasm with PDGFRB Rearrangement: Case Report with Imatinib Therapy and Review of the Literature
por: De Luca-Johnson, Javier, et al.
Publicado: (2016)

International Consensus Classification of myeloid and lymphoid neoplasms: myeloproliferative neoplasms
por: Gianelli, Umberto, et al.
Publicado: (2022)

The preclinical efficacy of the novel hypomethylating agent NTX-301 as a monotherapy and in combination with venetoclax in acute myeloid leukemia
por: Lim, Byungho, et al.
Publicado: (2022)

Myeloid/Lymphoid Neoplasm With FGFR1 Rearrangement Accompanying RUNX1 and NOTCH1 Gene Mutations
por: Wang, Xiaoxue, et al.
Publicado: (2019)

Imatinib in chronic myeloid leukemia elderly patients
por: Gugliotta, Gabriele, et al.
Publicado: (2011)

Loeffler endocarditis in chronic eosinophilic leukemia with FIP1L1/PDGFRA rearrangement: full recovery with low dose imatinib
por: Kim, Dae Sik, et al.
Publicado: (2018)

Genomic and clinical findings in myeloid neoplasms with PDGFRB rearrangement
por: Di Giacomo, Danika, et al.
Publicado: (2021)

Isolated Orbital Myeloid Sarcoma as a Therapy-related Myeloid Neoplasm
por: Ishiguro, Kazuya, et al.
Publicado: (2018)

Celecoxib suppresses autophagy and enhances cytotoxicity of imatinib in imatinib-resistant chronic myeloid leukemia cells
por: Lu, Ying, et al.
Publicado: (2016)

Dasatinib in the treatment of imatinib refractory chronic myeloid leukemia
por: Ramchandren, Radhakrishnan, et al.
Publicado: (2009)

Monitoring imatinib plasma concentrations in chronic myeloid leukemia
por: Martins, Darlize Hübner, et al.
Publicado: (2011)

Targeted treatment of chronic myeloid leukemia: role of imatinib
por: Tamascar, Ila, et al.
Publicado: (2009)

Therapy of Chronic Myeloid Leukemia: Twilight of the Imatinib Era?
por: Trela, Ewelina, et al.
Publicado: (2014)

Renal tuberculosis in an imatinib-treated chronic myeloid leukemia
por: Chandra, Abhilash, et al.
Publicado: (2020)

Chronic phase of chronic myeloid leukemia presenting with myeloid sarcoma in an adolescent
por: Lee, Hee Jin, et al.
Publicado: (2020)

B-Cell Chronic Lymphocytic Leukemia with 11q22.3 Rearrangement in Patient with Chronic Myeloid Leukemia Treated with Imatinib
por: Lewandowski, Krzysztof, et al.
Publicado: (2016)

RTK-RAS pathway mutation is enriched in myeloid sarcoma
por: Choi, Mihong, et al.
Publicado: (2018)

Plasmacytoid Dendritic Cells Proliferation Coexisted with Acute Myeloid Leukemia
por: Wang, Min, et al.
Publicado: (2018)

Cutaneous myeloid sarcoma associated with chronic myeloid leukemia
por: Vasconcelos, Erica Rodrigues de Araujo, et al.
Publicado: (2017)

P1063: A SINGLE CENTER EXPERIENCE OF DIAGNOSTICS AND TREATMENT OF RARE MYELOID/LYMPHOID NEOPLASMS WITH PDGFRB GENE REARRANGEMENT
por: Nemchenko, Irina, et al.
Publicado: (2023)

Incidental detection of myeloid/lymphoid neoplasms with fibroblast growth factor receptor 1 rearrangement on fluorodeoxyglucose positron emission tomography
por: Kobayashi, Hiroki, et al.
Publicado: (2023)

Chronic eosinophilic leukemia with FIP1L1-PDGFRA rearrangement
por: Kim, Tae Hee, et al.
Publicado: (2016)

The impact of the combination of KIT mutation and minimal residual disease on outcome in t(8;21) acute myeloid leukemia
por: Qin, Ya-Zhen, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_l1thv6hbdljind6uhtshstjgdl